| NEURIZON THERAPEUTICS |
| Australien |
| Gesundheit |
| AU0000357261 / A40STF |
| ECQ0 (Frankfurt) |
| FRA:ECQ0, ETR:ECQ0, ECQ0:GR |
| - |
| https://www.neurizon.com/ |
|
Neurizon Therapeutics Ltd is a clinical-stage biotechnology company specializing in the development of therapeutics for neurodegenerative diseases. Founded in 2000 and headquartered in Melbourne, Australia, the company focuses on innovative drug disc..
>Volltext.. |
| 33.07 Mio. EUR |
| 29.47 Mio. EUR |
| - |
| -12.05 Mio. EUR |
| -8.58 Mio. EUR |
| -0.02 EUR |
| 0.94 Mio. EUR |
| 4.58 Mio. EUR |
| -10.09 Mio. EUR |
| 1.13 |
| - |
| 3.15% |
| - |
| - |
| - |
| - |
| NEURIZON |
| 05.04.26 |
|